Skip to main content
Cellid Co., Ltd. logo

Cellid Co., Ltd. — Investor Relations & Filings

Ticker · 299660 ISIN · KR7299660001 KO Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2025-05-26 Capital/Financing Update
Country KR South Korea
Listing KO 299660

About Cellid Co., Ltd.

http://www.cellid.co.kr

Cellid Co., Ltd. is a research and development biotechnology company focused on immunotherapeutic vaccines. The company's activities are centered on two proprietary technology platforms: CeliVax for anti-cancer immunotherapy and an adenovirus vector platform for infectious disease vaccines. The CeliVax platform is used to develop personalized vaccines that utilize a patient's own B cells and monocytes to target specific cancer antigens. The adenovirus vector platform enables the rapid development of safe, non-replicating viral vector vaccines, with a key application being its COVID-19 vaccine candidate. Cellid's pipeline is built upon these core technologies to address unmet medical needs in oncology and virology.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권) (2025.06)
Capital/Financing Update Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by Cellid Co., Ltd. It details amendments to a previous securities registration statement, including updates to investment risk factors, litigation disclosures, and underwriting terms for a capital increase (rights offering). This is a formal regulatory filing required by the Financial Supervisory Service (DART) in South Korea for public offerings. It does not fit into the 'Report Publication Announcement' (RPA) category because it is the substantive regulatory document itself, not a notice of one.
2025-05-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the change in share ownership by a director (곽의종) of the company (주)셀리드, specifically noting a '장내매도' (on-market sale) of shares. This is a standard regulatory filing for insider trading/director dealings in the Korean market.
2025-05-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the '5% rule' report). It details changes in share ownership by the company's CEO (Kang Chang-yul) and his special related parties. This document type is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant changes in share ownership levels.
2025-05-26 Korean
소송등의제기ㆍ신청(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding a lawsuit ('소송등의제기ㆍ신청') filed against the company, Cellid. It details the plaintiff, the claim amount, the nature of the legal dispute, and the company's planned response. This falls directly under the category of legal proceedings and regulatory disclosures regarding litigation.
2025-05-23 Korean
[기재정정]증권신고서(지분증권) (2025.06)
Capital/Financing Update Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by Cellid Co., Ltd. It details specific amendments to a previously filed securities registration statement, including updates to financial data following the submission of the Q1 2025 report, changes in underwriting terms, and revisions to risk factors. This is a formal regulatory filing related to capital raising and securities issuance, which falls under the 'Regulatory Filings' category as it is a specific type of financial disclosure document that does not fit into the other specialized categories like 10-K or Earnings Release.
2025-05-13 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Cellid Co., Ltd.' covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial information, business operations, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-12 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.